Global Lenalidomide Market Growth 2022-2028

  • receipt Report ID : 322470
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 144
  • list Pharmaceuticals and Healthcare
Buy @ $3660

As the global economy mends, the 2021 growth of Lenalidomide will have significant change from previous year. According to our latest study, the global Lenalidomide market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Lenalidomide market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Lenalidomide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lenalidomide market, reaching US$ million by the year 2028. As for the Europe Lenalidomide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Lenalidomide players cover Celgene, SL Pharma, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Lenalidomide market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

5 mg Capsules

10 mg Capsules

15 mg Capsules

25 mg Capsules

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Multiple myeloma (MM)

Myelodysplastic syndromes (MDS)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Celgene

SL Pharma

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Lenalidomide Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Lenalidomide by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Lenalidomide by Country/Region, 2017, 2022 & 2028

2.2 Lenalidomide Segment by Type

2.2.1 5 mg Capsules

2.2.2 10 mg Capsules

2.2.3 15 mg Capsules

2.2.4 25 mg Capsules

2.3 Lenalidomide Sales by Type

2.3.1 Global Lenalidomide Sales Market Share by Type (2017-2022)

2.3.2 Global Lenalidomide Revenue and Market Share by Type (2017-2022)

2.3.3 Global Lenalidomide Sale Price by Type (2017-2022)

2.4 Lenalidomide Segment by Application

2.4.1 Multiple myeloma (MM)

2.4.2 Myelodysplastic syndromes (MDS)

2.5 Lenalidomide Sales by Application

2.5.1 Global Lenalidomide Sale Market Share by Application (2017-2022)

2.5.2 Global Lenalidomide Revenue and Market Share by Application (2017-2022)

2.5.3 Global Lenalidomide Sale Price by Application (2017-2022)

3 Global Lenalidomide by Company

3.1 Global Lenalidomide Breakdown Data by Company

3.1.1 Global Lenalidomide Annual Sales by Company (2020-2022)

3.1.2 Global Lenalidomide Sales Market Share by Company (2020-2022)

3.2 Global Lenalidomide Annual Revenue by Company (2020-2022)

3.2.1 Global Lenalidomide Revenue by Company (2020-2022)

3.2.2 Global Lenalidomide Revenue Market Share by Company (2020-2022)

3.3 Global Lenalidomide Sale Price by Company

3.4 Key Manufacturers Lenalidomide Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Lenalidomide Product Location Distribution

3.4.2 Players Lenalidomide Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Lenalidomide by Geographic Region

4.1 World Historic Lenalidomide Market Size by Geographic Region (2017-2022)

4.1.1 Global Lenalidomide Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Lenalidomide Annual Revenue by Geographic Region

4.2 World Historic Lenalidomide Market Size by Country/Region (2017-2022)

4.2.1 Global Lenalidomide Annual Sales by Country/Region (2017-2022)

4.2.2 Global Lenalidomide Annual Revenue by Country/Region

4.3 Americas Lenalidomide Sales Growth

4.4 APAC Lenalidomide Sales Growth

4.5 Europe Lenalidomide Sales Growth

4.6 Middle East & Africa Lenalidomide Sales Growth

5 Americas

5.1 Americas Lenalidomide Sales by Country

5.1.1 Americas Lenalidomide Sales by Country (2017-2022)

5.1.2 Americas Lenalidomide Revenue by Country (2017-2022)

5.2 Americas Lenalidomide Sales by Type

5.3 Americas Lenalidomide Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Lenalidomide Sales by Region

6.1.1 APAC Lenalidomide Sales by Region (2017-2022)

6.1.2 APAC Lenalidomide Revenue by Region (2017-2022)

6.2 APAC Lenalidomide Sales by Type

6.3 APAC Lenalidomide Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Lenalidomide by Country

7.1.1 Europe Lenalidomide Sales by Country (2017-2022)

7.1.2 Europe Lenalidomide Revenue by Country (2017-2022)

7.2 Europe Lenalidomide Sales by Type

7.3 Europe Lenalidomide Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Lenalidomide by Country

8.1.1 Middle East & Africa Lenalidomide Sales by Country (2017-2022)

8.1.2 Middle East & Africa Lenalidomide Revenue by Country (2017-2022)

8.2 Middle East & Africa Lenalidomide Sales by Type

8.3 Middle East & Africa Lenalidomide Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Lenalidomide

10.3 Manufacturing Process Analysis of Lenalidomide

10.4 Industry Chain Structure of Lenalidomide

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Lenalidomide Distributors

11.3 Lenalidomide Customer

12 World Forecast Review for Lenalidomide by Geographic Region

12.1 Global Lenalidomide Market Size Forecast by Region

12.1.1 Global Lenalidomide Forecast by Region (2023-2028)

12.1.2 Global Lenalidomide Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Lenalidomide Forecast by Type

12.7 Global Lenalidomide Forecast by Application

13 Key Players Analysis

13.1 Celgene

13.1.1 Celgene Company Information

13.1.2 Celgene Lenalidomide Product Offered

13.1.3 Celgene Lenalidomide Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Celgene Main Business Overview

13.1.5 Celgene Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Lenalidomide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Lenalidomide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 5 mg Capsules

Table 4. Major Players of 10 mg Capsules

Table 5. Major Players of 15 mg Capsules

Table 6. Major Players of 25 mg Capsules

Table 7. Global Lenalidomide Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Lenalidomide Sales Market Share by Type (2017-2022)

Table 9. Global Lenalidomide Revenue by Type (2017-2022) & ($ million)

Table 10. Global Lenalidomide Revenue Market Share by Type (2017-2022)

Table 11. Global Lenalidomide Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Lenalidomide Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Lenalidomide Sales Market Share by Application (2017-2022)

Table 14. Global Lenalidomide Revenue by Application (2017-2022)

Table 15. Global Lenalidomide Revenue Market Share by Application (2017-2022)

Table 16. Global Lenalidomide Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Lenalidomide Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Lenalidomide Sales Market Share by Company (2020-2022)

Table 19. Global Lenalidomide Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Lenalidomide Revenue Market Share by Company (2020-2022)

Table 21. Global Lenalidomide Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Lenalidomide Producing Area Distribution and Sales Area

Table 23. Players Lenalidomide Products Offered

Table 24. Lenalidomide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Lenalidomide Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Lenalidomide Sales Market Share Geographic Region (2017-2022)

Table 29. Global Lenalidomide Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Lenalidomide Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Lenalidomide Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Lenalidomide Sales Market Share by Country/Region (2017-2022)

Table 33. Global Lenalidomide Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Lenalidomide Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Lenalidomide Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Lenalidomide Sales Market Share by Country (2017-2022)

Table 37. Americas Lenalidomide Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Lenalidomide Revenue Market Share by Country (2017-2022)

Table 39. Americas Lenalidomide Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Lenalidomide Sales Market Share by Type (2017-2022)

Table 41. Americas Lenalidomide Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Lenalidomide Sales Market Share by Application (2017-2022)

Table 43. APAC Lenalidomide Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Lenalidomide Sales Market Share by Region (2017-2022)

Table 45. APAC Lenalidomide Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Lenalidomide Revenue Market Share by Region (2017-2022)

Table 47. APAC Lenalidomide Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Lenalidomide Sales Market Share by Type (2017-2022)

Table 49. APAC Lenalidomide Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Lenalidomide Sales Market Share by Application (2017-2022)

Table 51. Europe Lenalidomide Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Lenalidomide Sales Market Share by Country (2017-2022)

Table 53. Europe Lenalidomide Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Lenalidomide Revenue Market Share by Country (2017-2022)

Table 55. Europe Lenalidomide Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Lenalidomide Sales Market Share by Type (2017-2022)

Table 57. Europe Lenalidomide Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Lenalidomide Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Lenalidomide Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Lenalidomide Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Lenalidomide Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Lenalidomide Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Lenalidomide Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Lenalidomide Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Lenalidomide Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Lenalidomide Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Lenalidomide

Table 68. Key Market Challenges & Risks of Lenalidomide

Table 69. Key Industry Trends of Lenalidomide

Table 70. Lenalidomide Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Lenalidomide Distributors List

Table 73. Lenalidomide Customer List

Table 74. Global Lenalidomide Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Lenalidomide Sales Market Forecast by Region

Table 76. Global Lenalidomide Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Lenalidomide Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Lenalidomide Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Lenalidomide Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Lenalidomide Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Lenalidomide Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Lenalidomide Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Lenalidomide Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Lenalidomide Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Lenalidomide Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Lenalidomide Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Lenalidomide Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Lenalidomide Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Lenalidomide Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Lenalidomide Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Lenalidomide Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Lenalidomide Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Lenalidomide Revenue Market Share Forecast by Application (2023-2028)

Table 94. Celgene Basic Information, Lenalidomide Manufacturing Base, Sales Area and Its Competitors

Table 95. Celgene Lenalidomide Product Offered

Table 96. Celgene Lenalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Celgene Main Business

Table 98. Celgene Latest Developments

Table 99. SL Pharma Basic Information, Lenalidomide Manufacturing Base, Sales Area and Its Competitors

Table 100. SL Pharma Lenalidomide Product Offered

Table 101. SL Pharma Lenalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. SL Pharma Main Business

Table 103. SL Pharma Latest Developments

List of Figures

Figure 1. Picture of Lenalidomide

Figure 2. Lenalidomide Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Lenalidomide Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Lenalidomide Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Lenalidomide Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 5 mg Capsules

Figure 10. Product Picture of 10 mg Capsules

Figure 11. Product Picture of 15 mg Capsules

Figure 12. Product Picture of 25 mg Capsules

Figure 13. Global Lenalidomide Sales Market Share by Type in 2021

Figure 14. Global Lenalidomide Revenue Market Share by Type (2017-2022)

Figure 15. Lenalidomide Consumed in Multiple myeloma (MM)

Figure 16. Global Lenalidomide Market: Multiple myeloma (MM) (2017-2022) & (K Pcs)

Figure 17. Lenalidomide Consumed in Myelodysplastic syndromes (MDS)

Figure 18. Global Lenalidomide Market: Myelodysplastic syndromes (MDS) (2017-2022) & (K Pcs)

Figure 19. Global Lenalidomide Sales Market Share by Application (2017-2022)

Figure 20. Global Lenalidomide Revenue Market Share by Application in 2021

Figure 21. Lenalidomide Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Lenalidomide Revenue Market Share by Company in 2021

Figure 23. Global Lenalidomide Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Lenalidomide Revenue Market Share by Geographic Region in 2021

Figure 25. Global Lenalidomide Sales Market Share by Region (2017-2022)

Figure 26. Global Lenalidomide Revenue Market Share by Country/Region in 2021

Figure 27. Americas Lenalidomide Sales 2017-2022 (K Pcs)

Figure 28. Americas Lenalidomide Revenue 2017-2022 ($ Millions)

Figure 29. APAC Lenalidomide Sales 2017-2022 (K Pcs)

Figure 30. APAC Lenalidomide Revenue 2017-2022 ($ Millions)

Figure 31. Europe Lenalidomide Sales 2017-2022 (K Pcs)

Figure 32. Europe Lenalidomide Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Lenalidomide Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Lenalidomide Revenue 2017-2022 ($ Millions)

Figure 35. Americas Lenalidomide Sales Market Share by Country in 2021

Figure 36. Americas Lenalidomide Revenue Market Share by Country in 2021

Figure 37. United States Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Lenalidomide Sales Market Share by Region in 2021

Figure 42. APAC Lenalidomide Revenue Market Share by Regions in 2021

Figure 43. China Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Lenalidomide Sales Market Share by Country in 2021

Figure 50. Europe Lenalidomide Revenue Market Share by Country in 2021

Figure 51. Germany Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Lenalidomide Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Lenalidomide Revenue Market Share by Country in 2021

Figure 58. Egypt Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Lenalidomide Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Lenalidomide in 2021

Figure 64. Manufacturing Process Analysis of Lenalidomide

Figure 65. Industry Chain Structure of Lenalidomide

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz